Promising new pill may help kids with rare leukemia
NCT ID NCT07354074
First seen Jan 24, 2026 · Last updated May 23, 2026 · Updated 17 times
Summary
This study tests a drug called asciminib in children aged 1 to 18 with a specific type of leukemia (Ph+ CML-CP). The goal is to see if the drug can reduce cancer cells to very low levels. About 50 children will take the drug daily, either as a liquid or pill. This is not a cure, but aims to control the disease long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MYELOGENOUS LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Novartis Investigative Site
RECRUITINGBrisbane, Queensland, 4101, Australia
-
Novartis Investigative Site
RECRUITINGSeoul, 03080, South Korea
Conditions
Explore the condition pages connected to this study.